临床研究
Copyright ©The Author(s) 2025.
世界华人消化杂志. 2025-06-28; 33(6): 499-506
在线出版 2025-06-28. doi: 10.11569/wcjd.v33.i6.499
表1 两组基线资料比较, n(%)
项目观察组(n = 130)对照组(n = 130)t/χ2P
性别0.5770.448
81(62.31)75(57.69)
49(37.69)55(42.31)
年龄(岁)58.42±9.1456.79±7.251.5930.112
体质指数(kg/m2)23.59±2.1723.14±1.791.8240.069
T2DM病程(年)3.64±0.653.52±0.701.4320.153
吸烟史56(43.08)50(38.46)0.5730.449
饮酒史53(40.77)56(43.08)0.1420.706
FPG(mmol/L)8.47±1.327.98±1.253.0730.002
HbAlc(%)9.17±1.438.57±1.333.5030.001
TG(mmol/L)1.61±0.271.58±0.250.9300.353
TC(mmol/L)5.68±1.235.52±0.981.1600.247
LDL-C(mmol/L)2.72±0.432.69±0.370.6030.547
HDL-C(mmol/L)1.08±0.191.12±0.231.5290.128
BUN(mmol/L)6.45±1.835.57±1.62
Scr(μmol/L)97.83±20.1584.74±14.37
表2 两组肠道菌群比较(mean±SD, lgCFU/g)
组别例数乳酸杆菌双歧杆菌大肠埃希菌粪肠球菌链球菌
观察组1305.47±1.125.84±1.456.72±1.437.59±1.546.64±1.32
对照组1306.37±1.426.59±1.565.88±1.526.47±1.325.19±0.97
t 5.674 4.0154.589 6.296 10.093
P<0.001<0.001<0.001<0.001<0.001
表3 肠道菌群与血糖、肾功能指标水平的相关性
项目乳酸杆菌双歧杆菌大肠埃希菌粪肠球菌链球菌
FPGr-0.502-0.5110.4910.4990.502
P<0.001<0.001<0.001<0.001<0.001
HbAlcr-0.498-0.5070.4780.4830.495
P<0.001<0.001<0.001<0.001<0.001
BUNr-0.574-0.5920.5220.5370.547
P<0.001<0.001<0.001<0.001<0.001
Scrr-0.541-0.5780.5090.5090.512
P<0.001<0.001<0.001<0.001<0.001
表4 肠道菌群与2型糖尿病早期肾损害的关系
因素βSEWald χ2POR95%CI
模型1
乳酸杆菌-0.1330.0497.388<0.0010.8750.785-0.976
双歧杆菌-0.1370.0478.471<0.0010.8720.794-0.958
大肠埃希菌0.4670.1667.915<0.0011.5951.224-2.079
粪肠球菌0.4820.1589.322<0.0011.6201.305-2.011
链球菌0.4720.14710.294<0.0011.6031.219-2.107
模型2
乳酸杆菌-0.1550.0528.911<0.0010.8560.790-0.928
双歧杆菌-0.1530.0567.422<0.0010.8590.802-0.919
大肠埃希菌0.4730.1727.566<0.0011.6051.229-2.096
粪肠球菌0.4950.1609.582<0.0011.6411.345-2.002
链球菌0.4870.1599.364<0.0011.6271.274-2.077
模型3
乳酸杆菌-0.1560.0577.460<0.0010.8560.804-0.911
双歧杆菌-0.1520.0606.393<0.0010.8590.814-0.907
大肠埃希菌0.4310.1706.434<0.0011.5391.194-1.984
粪肠球菌0.4710.1628.442<0.0011.6011.285-1.995
链球菌0.4430.1607.662<0.0011.5571.207-2.009

引文著录: 周斌. 2型糖尿病患者肠道菌群与早期肾损害的关系探讨. 世界华人消化杂志 2025; 33(6): 499-506